GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » E10

Celltrion (XKRX:068270) E10 : ₩2,671.03 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Celltrion E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Celltrion's adjusted earnings per share data for the three months ended in Mar. 2024 was ₩108.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩2,671.03 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Celltrion's average E10 Growth Rate was 10.50% per year. During the past 3 years, the average E10 Growth Rate was 14.90% per year. During the past 5 years, the average E10 Growth Rate was 15.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Celltrion was 18.10% per year. The lowest was 14.90% per year. And the median was 15.80% per year.

As of today (2024-06-04), Celltrion's current stock price is ₩188100.00. Celltrion's E10 for the quarter that ended in Mar. 2024 was ₩2,671.03. Celltrion's Shiller PE Ratio of today is 70.42.

During the past 13 years, the highest Shiller PE Ratio of Celltrion was 283.16. The lowest was 51.18. And the median was 107.57.


Celltrion E10 Historical Data

The historical data trend for Celltrion's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion E10 Chart

Celltrion Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,488.20 1,759.68 2,088.98 2,303.16 2,672.01

Celltrion Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,417.59 2,502.63 2,676.88 2,672.01 2,671.03

Competitive Comparison of Celltrion's E10

For the Biotechnology subindustry, Celltrion's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celltrion's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celltrion's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Celltrion's Shiller PE Ratio falls into.



Celltrion E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Celltrion's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=108/118.8477*118.8477
=108.000

Current CPI (Mar. 2024) = 118.8477.

Celltrion Quarterly Data

per share eps CPI Adj_EPS
201406 455.200 99.353 544.518
201409 106.536 99.608 127.114
201412 119.090 99.098 142.824
201503 -103.258 99.720 -123.064
201506 401.298 100.050 476.695
201509 390.347 100.110 463.409
201512 308.851 100.220 366.257
201603 72.515 100.560 85.702
201606 389.971 100.790 459.839
201609 381.914 101.460 447.364
201612 252.877 101.560 295.922
201703 456.847 102.850 527.907
201706 772.409 102.610 894.640
201709 695.422 103.490 798.621
201712 658.857 102.990 760.303
201803 546.236 104.100 623.620
201806 541.059 104.130 617.532
201809 378.827 105.650 426.150
201812 221.170 104.350 251.898
201903 418.971 104.490 476.541
201906 506.990 104.880 574.510
201909 403.128 105.200 455.426
201912 744.818 105.120 842.084
202003 708.862 105.540 798.243
202006 931.594 104.870 1,055.762
202009 1,148.780 106.200 1,285.592
202012 769.416 105.765 864.586
202103 1,316.930 107.357 1,457.882
202106 850.302 107.579 939.373
202109 918.175 108.759 1,003.345
202112 896.324 109.676 971.276
202203 788.462 111.806 838.122
202206 1,225.000 114.083 1,276.165
202209 1,116.350 114.831 1,155.396
202212 608.115 115.200 627.369
202303 1,155.000 116.550 1,177.774
202306 1,034.000 117.140 1,049.075
202309 1,561.000 119.111 1,557.547
202312 9.000 118.848 9.000
202403 108.000 118.848 108.000

Add all the adjusted EPS together and divide 10 will get our e10.


Celltrion  (XKRX:068270) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Celltrion's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=188100.00/2671.03
=70.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Celltrion was 283.16. The lowest was 51.18. And the median was 107.57.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Celltrion E10 Related Terms

Thank you for viewing the detailed overview of Celltrion's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Celltrion (XKRX:068270) Business Description

Traded in Other Exchanges
N/A
Address
13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion (XKRX:068270) Headlines

No Headlines